Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hewei Jiangni Decoction (Beijing University of Chinese Medicine East Hospital)
- Development stage
- Unknown
- Lead developer
- Beijing University of Chinese Medicine East Hospital
- Administration
- Oral
01
Overview
Hewei Jiangni Decoction is a Traditional Chinese Medicine (TCM) herbal formulation developed by the Dongfang Hospital of Beijing University of Chinese Medicine. It is specifically indicated for the treatment of non-erosive gastroesophageal reflux disease (NERD), particularly for patients diagnosed with the cold and heat mixed syndrome according to TCM principles. The name of the decoction reflects its primary therapeutic goals: Hewei (harmonizing the stomach) and Jiangni (lowering the adverse flow of qi), which are intended to alleviate symptoms like acid reflux and heartburn. As a complex botanical mixture, it is administered orally and is currently being evaluated in randomized, double-blind clinical trials to establish its efficacy and safety compared to standard pharmacological treatments like proton pump inhibitors.
- Other names
- Hewei Jiangni Tang
02
Targets
IL1B (Interleukin-1 beta)IL8 (C-X-C Motif Chemokine Ligand 8)MMP9 (Matrix metalloproteinase-9)EGFR T790M (Epidermal growth factor receptor T790M mutant)IL-6 (Interleukin 6)
Beyond the preview
Go deeper on Hewei Jiangni Decoction (Beijing University of Chinese Medicine East Hospital).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hewei Jiangni Decoction (Beijing University of Chinese Medicine East Hospital).